AI Article Synopsis

Article Abstract

From January 1978 to December 1988, 54 males and 59 females were treated for varicella, zoster and disseminated zoster by varicella-zoster immunoglobulin (group I) or acyclovir (group II). 67 patients had immune deficiency disease. Treatment was successful for 92/100 patients in group I and for 100/100 patients in group II. Thrombophlebitis and renal failure were observed in group II and regressed when acyclovir was stopped. Varicella-zoster immunoglobulin and acyclovir are two effective therapeutics in the treatment of varicella and zoster in adults including immunocompromised patients. The use of acyclovir could not reduce the duration of hospitalization.

Download full-text PDF

Source

Publication Analysis

Top Keywords

varicella zoster
8
varicella-zoster immunoglobulin
8
patients group
8
group
5
[acyclovir specific
4
specific anti-varicella-herpes
4
zoster
4
anti-varicella-herpes zoster
4
zoster immunoglobulins
4
immunoglobulins treatment
4

Similar Publications

Herpes zoster (HZ) is a viral infection caused by the reactivation of endogenous and latent varicella-zoster virus that remains dormant in the cranial nerve or dorsal root ganglia. HZ occurs in a portion of the general population, with a higher incidence observed in high-risk individuals. Patients with impaired immunity, including human immunodeficiency virus infection, organ transplantation, old age, and cancer-related treatments such as chemotherapy (CT) and radiotherapy (RT) were found more prone to HZ infection.

View Article and Find Full Text PDF

Insights into pathologic mechanisms occurring during serious adverse events following live zoster vaccination.

J Virol

January 2025

Division of Infectious Diseases, Virology Laboratory, Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA.

An effective live zoster vaccine has been widely used around the world. Although no deaths occurred in the original large clinical trial, we analyzed 10 serious adverse events, including six deaths that have subsequently occurred in four countries. The goal is to define the viral pathogenesis of these unexpected adverse events secondary to a viremia with dissemination of the vaccine virus.

View Article and Find Full Text PDF

In this case, we present the case of a 74-year-old female patient who visited the University Hospital of Patras, Greece, because of a 10-day history of earache and discharge in the left ear. Concurrently, the patient exhibited ipsilateral peripheral facial nerve palsy. We also observed vesicular eruption at the auricle and the external auditory canal (EAC) of the left ear.

View Article and Find Full Text PDF

A Case of Fournier's Gangrene Secondary to Varicella Zoster Virus in a 7-Year-Old Boy.

Case Rep Surg

January 2025

Department of Plastic and Reconstructive Surgery, Cork University Hospital, Cork, County Cork, Ireland.

A rare case of Fournier's gangrene (FG) secondary to varicella-zoster virus (VZV) affecting the penis and scrotum of a 7-year-old boy is presented. To the authors' knowledge, there are four cases of FG in children as a result of VZV reported to date. Our patient underwent a total of four surgical debridements and was reconstructed using a split-thickness skin graft (SSG).

View Article and Find Full Text PDF

Varicella challenges: A case of respiratory tract complications in an elderly patient.

Narra J

December 2024

Department of Dermatology Venereology and Aesthetic, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Varicella, caused by the varicella-zoster virus (VZV), is rarely reported in the elderly but often complicates with pneumonia. In this case report, we present a case of varicella pneumonia in the elderly. A 60-year-old man presented to the emergency room with vesicles filled with clear fluid that had appeared all over the body for the past four days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!